HCA HCA Healthcare

XNYS Up Alert

Health Care

· How we analyze

About the company

HCA Healthcare is a private hospital operator from Tennessee. Its network includes hospitals, outpatient surgery centers, urgent care clinics and other facilities, mainly in the southern US, plus some sites in the UK. As of Oct 13, 2026

Fact sheet (from the annual report) Hospitals · Nashville, USA

HCA Healthcare operates general acute care hospitals, psychiatric hospitals and rehabilitation hospitals in many states and in England. In addition, there are ambulatory surgery centers, endoscopy centers, physician practices, diagnostic centers, home health services and hospices. The acute care hospitals generally cover specialties such as internal medicine, surgery, cardiology, oncology, orthopedics and obstetrics as well as diagnostics and emergency care. The psychiatric hospitals provide inpatient, partial hospitalization and outpatient treatment. Payments come from Medicare and Medicaid, from managed care health insurers, from private insurers and directly from patients.

Automatically summarized from SEC annual report (10-K, filed Feb 10, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026

What the methods say about HCA Healthcare

Calculated automatically by fixed rules – not investment advice, check for yourself. How we analyze

Price performance at a glance

Last 30 trading days
  • Today −0.8%
  • 7 days +2.3%
  • 30 days +6.8%
  • 1 year +4.1%
Day range (last trading day)
−0.8%Price at 30% of the range+2.0%
52-week range
−23.9%Price at 55% of the range+19.6%
Distance from the all-time high
−16.4%

Our own calculation from the exchange’s daily candles, as of Oct 26, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Load chart from TradingView

This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.

Symbol on TradingView: NYSE:HCA

Fundamental analysis

HCA Healthcare · Sector Health Care · amounts in USD

Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 10, 2026.

In short

  • Light green: Revenue grew over 5 years (+8.0% per year), at least as fast as the sector median.
  • Light green: Net income (total) grew over 5 years (+12.6% per year), at least as fast as the sector median; per share +21.0% per year.
  • Light yellow: Net margin 9.0%, below the sector median (12.9%).
  • Light green: Profit in each of the last 10 fiscal years.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 41.5B USD · Net income 2.9B USD · Net margin 7.0%
  2. Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 43.6B USD · Net income 2.2B USD · Net margin 5.1%
  3. Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 46.7B USD · Net income 3.8B USD · Net margin 8.1%
  4. Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 51.3B USD · Net income 3.5B USD · Net margin 6.8%
  5. Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 51.5B USD · Net income 3.8B USD · Net margin 7.3%
  6. Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 58.8B USD · Net income 7.0B USD · Net margin 11.8%
  7. Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 60.2B USD · Net income 5.6B USD · Net margin 9.4%
  8. Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 65.0B USD · Net income 5.2B USD · Net margin 8.1%
  9. Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 70.6B USD · Net income 5.8B USD · Net margin 8.2%
  10. Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 75.6B USD · Net income 6.8B USD · Net margin 9.0%

Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 75.6B USD · Net income 6.8B USD · Net margin 9.0%

Key figures with traffic lights

Each light follows a simple, disclosed rule. The comparison is with the sector median of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).

Revenue growth

Light green: above sector

+8.0% per year, last 5 years

Sector Health Care: median +7.8% (60 symbols)

What does this mean? Revenue: over 5 years it grew by 8.0% per year on average – at least as fast as the median company in the sector (+7.8%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light green: above sector

+12.6% per year, last 5 years

Sector Health Care: median +7.5% (46 symbols)

per share: +21.0% per year (5 years, split-adjusted)

What does this mean? Total net income: over 5 years it grew by 12.6% per year on average – at least as fast as the median company in the sector (+7.5%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light yellow: below sector

9.0% last fiscal year

Sector Health Care: median 12.9% (63 symbols)

What does this mean? Of every 100 USD in revenue, 8.97 USD remained as profit – less than the median company in the sector (12.9%). Five years ago the margin was 7.3%.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light gray: negative equity

– latest balance sheet

Sector Health Care: median 0.66 (40 symbols)

What does this mean? Equity is negative (e.g. due to share buybacks). A debt-to-equity ratio cannot be formed meaningfully then.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light green: covered

10% Dividend / earnings per share

Sector Health Care: median 28% (31 symbols)

What does this mean? Of every 1 USD of earnings per share, 0.10 USD went to shareholders as a dividend. The rest stays in the company. Median company in the sector: 28%.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light green: profit every year

10 of 10 fiscal years with a profit

What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
75.6B USD
Revenue vs. prior year
+7.1%
Net income (FY)
6.8B USD
Net income vs. prior year
+17.8%
EPS (FY)
28.33 USD
13F funds with a position
0 of 9
Funds vs. prior quarter
±0
Shares held vs. prior quarter
–
Fiscal year to Dec 31, 2025 · 10-K filed Feb 10, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). 13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2025Dec 31, 2025 75.6B6.8B 9.0% 28.33 2.88 10%
2024Dec 31, 2024 70.6B5.8B 8.2% 22.00 2.64 12%
2023Dec 31, 2023 65.0B5.2B 8.1% 18.97 2.40 13%
2022Dec 31, 2022 60.2B5.6B 9.4% 19.15 2.24 12%
2021Dec 31, 2021 58.8B7.0B 11.8% 21.16 1.92 9%
2020Dec 31, 2020 51.5B3.8B 7.3% 10.93 0.43 4%
2019Dec 31, 2019 51.3B3.5B 6.8% 10.07 1.60 16%
2018Dec 31, 2018 46.7B3.8B 8.1% 10.66 1.40 13%
2017Dec 31, 2017 43.6B2.2B 5.1% 5.95 – –
2016Dec 31, 2016 41.5B2.9B 7.0% 7.30 – –
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q1/26Mar 31, 2026 19.1B1.6B 8.5% 7.15 0.78 11%
Q4/25*Dec 31, 2025 19.5B1.9B 9.6% – 0.72 –
Q3/25Sep 30, 2025 19.2B1.6B 8.6% 6.96 0.72 10%
Q2/25Jun 30, 2025 18.6B1.7B 8.9% 6.83 0.72 11%
Q1/25Mar 31, 2025 18.3B1.6B 8.8% 6.45 0.72 11%
Q4/24*Dec 31, 2024 18.3B1.4B 7.9% – 0.66 –
Q3/24Sep 30, 2024 17.5B1.3B 7.3% 4.88 0.66 14%
Q2/24Jun 30, 2024 17.5B1.5B 8.4% 5.53 0.66 12%
Q1/24Mar 31, 2024 17.3B1.6B 9.2% 5.93 0.66 11%
Q4/23*Dec 31, 2023 17.3B1.6B 9.3% – 0.60 –
Q3/23Sep 30, 2023 16.2B1.1B 6.7% 3.91 0.60 15%
Q2/23Jun 30, 2023 15.9B1.2B 7.5% 4.29 0.60 14%

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $00 people $0
6 months $00 people $00 people $0
12 months $00 people $31.1M5 people −$31.1M

Latest transactions

  • Feb 18, 2026 McAlevey Michael R Officer Open-market sale 1,694 shares · $903.5K · SEC
  • Feb 11, 2026 Wyatt Christopher F. Officer Open-market sale 4,000 shares · $2.0M · SEC
  • Feb 11, 2026 Berres Jennifer Officer Open-market sale 4,010 shares · $2.1M · SEC
  • Feb 11, 2026 Berres Jennifer Officer Open-market sale 4,010 shares · $2.0M · SEC
  • Feb 3, 2026 Hazen Samuel N Chief executive (CEO), Director Open-market sale 120 shares · $59.7K · SEC
  • Feb 3, 2026 Hazen Samuel N Chief executive (CEO), Director Open-market sale 4,293 shares · $2.1M · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Trend score +100

Price vs. EMA 50+15
Price vs. EMA 200+15
EMA 50 vs. EMA 200+20
ADX (trend strength)+15
Highs and lows+20
Relative strength+15

Volatility and trend strength

ADX 14 (trend strength)30.3
Rel. strength 60 d+13.6%

ATR and moving averages as price values only when logged in.

More stocks from Health Care

All symbols in this sector

News

Latest news

Posts

No posts on HCA yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: HCA

Alerts with a free account: we send you an email as soon as the price moves above or below your level, reaches the buy zone or the buy zone becomes invalid.

Checked after every data update: crypto hourly (buy zones every 4 hours), stocks twice a day, precious metals every 4 hours on trading days, extended universe weekly – not in real time.

Log in Sign up free

↑ ↓ select · Enter open · Esc close